The mTOR pathway as a potential target for the development of therapies against neurological disease

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• The mammalian target of rapamycin (mTOR) is a key protein kinase regulating cellular processes like proliferation, survival, and autophagy.
• mTOR activity is influenced by nutrient and energy levels, impacting cell proliferation during deprivation.
• mTOR is implicated in inhibiting apoptosis and clearing protein aggregates, processes relevant to neurodegeneration.

Purpose of the Study:

• To examine the multifaceted effects of mTOR.
• To explore the potential therapeutic applications of modulating mTOR activity in neurological diseases.
• To investigate mTOR's role in conditions like stroke, Alzheimer's, and Huntington's disease.

Main Methods:

• Review of existing literature on mTOR signaling pathways.
• Analysis of mTOR's involvement in cellular processes relevant to neurological disorders.
• Examination of preclinical and clinical data regarding mTOR modulation.

Main Results:

• mTOR regulates critical cellular functions including transcription, translation, and autophagy.
• Inhibition of mTOR can decrease cancer cell proliferation and increase apoptosis, proving effective in brain tumor therapy.
• Modulating mTOR activity may offer protective effects against neuronal death in neurodegenerative diseases.

Conclusions:

• Targeting mTOR presents a potential therapeutic strategy for various neurological conditions.
• Understanding mTOR's complex role is crucial for developing effective treatments for neurodegenerative diseases and brain tumors.
• Further research into mTOR modulation could lead to novel interventions for diseases involving cell death and protein aggregation.